Blue Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Blue Trust's GILD Position: Q3 2026 in Review
Blue Trust reduced its Gilead Sciences (GILD) stake by 38% in Q3 2026, selling an estimated $269K and leaving 3,080 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #508.
Blue Trust first reported a position in GILD in Q2 2022 and has held it in 18 quarters since. The position peaked at $677K in Q1 2026. 2,357 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Blue Trust held 3,080 shares of Gilead Sciences worth $459K as of Q3 2026.
- Blue Trust sold 1,916 Gilead Sciences shares in Q3 2026, an estimated $269K.
- Gilead Sciences made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #508 holding.
- Blue Trust first reported a position in Gilead Sciences in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Gilead Sciences position peaked at $677K in Q1 2026.
- 2,357 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.